Why markets already priced in a vaccine approval, stellar gains from AIM stocks in 2020, retail’s latest challenge and dealing with NS&I’s punishing rate cuts
The UK’s status as the first country in the world to approve Pfizer’s Covid vaccine failed to move stock markets on the day of the news. Listen to the podcast to find out why markets reacted in this way.
Tom Sieber from Shares magazine joins the show to discuss the reasons why the AIM market has done nearly as well as the US S&P 500 in 2020 and significantly outperformed large cap UK stocks in the FTSE 100.
The podcast looks at the large rate cuts on NS&I accounts and what savers can do to improve their situation. And the team also debate the latest in the retail sector after Debenham’s struggles and Arcadia going into administration.
Presented by AJ Bell’s Dan Coatsworth and Laith Khalaf
Latest podcasts:
We’ve got some good news from the UK stock market. Danni Hewson chats about how the FTSE 100 has hit a new record high and the drivers behind it. She also... Read more
Money & Markets Podcast | Wed, 24/04/2024 - 17:28
UK, Managing your investments, Market analysis, Shares and the stockmarket
Taylor Swift scams, Royal Mail takeover and latest twist to Woodford scandal
On this week’s AJ Bell Money & Markets podcast, Charlene Young and Dan Coatsworth look at cooling inflation and how markets reacted to the latest... Read more
Money & Markets Podcast | Thu, 18/04/2024 - 11:54
UK, Managing your investments, Shares and the stockmarket, Investment trusts
Meeting real-life Barbie and why the cost-of-living crisis isn’t over yet
On this episode Danni and Laura dig into the findings of a survey that reveals that more than 7 million households are still struggling to make ends meet... Read more
Money Matters Podcast | Wed, 17/04/2024 - 09:14